Support that hides contact info or leans too hard on AI is a red flag, especially when patients need help fast
Puedo decirles que el consenso entre los especialistas en endocrinologa de la obesidad que practican legtimamente es evitar esto, porque es demasiado desconocido, dijo Nadolsky
On March 5, Novo Nordisk released the top-line results from this pivotal kidney outcomes trial: Use of semaglutide in patients with diabetic kidney disease reduced the primary outcomea composite of kidney failure, 50% decline in estimated glomerular filtration rate (eGFR), and cardiovascular (CV) or kidney deathby an impressive 24% (Figure 1)
Trumps administration denies these claims, calling them sick and deranged in a post on X
Report any new or concerning symptoms promptly, attend scheduled follow-up appointments, and never adjust doses independently